Search PDMR transactions

Notifier
Name
Keith Alexander
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Keith Alexander
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Expres2ion Biotech Holding AB
LEI of Issuer
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Warrant ExpreS2ion Biotech Holding T04 SE0014958328 Acquisition 7,300 Quantity 6.90 SEK 09/03/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
ExpreS2ion Biotech Holding T04 SE0014958328 Acquisition 09/03/2021 NASDAQ STOCKHOLM AB 7,300 (Quantity) 6.90 SEK
Total: 7,300
<< Back